← back to search

Aaron Schindeler

The University of Sydney · AU
Area of research
Epidemiology · Biomedical Engineering
Research interest
Research interests include Bone fractures and treatments, Bone Tissue Engineering Materials, Orthopaedic implants and arthroplasty, and Neurofibromatosis and Schwannoma Cases.
h-index
42
citations
6,132
works
187
NIH funding
primary concept
email

Recent publications

In vivo precision base editing to rescue mouse models of disease
Molecular Therapy — Nucleic Acids 2025cited by 8position: firstdoi
Microencapsulation of <i>Bifidobacterium lactis</i> and <i>Lactobacillus plantarum</i> within a Novel Polysaccharide-Based Core–Shell Formulation: Improving Probiotic Viability and Mucoadhesion
ACS Biomaterials Science & Engineering 2024cited by 12position: middledoi
Strategies for senolytic drug discovery
Aging Cell 2023cited by 65position: lastdoi
Disease-modifying interactions between chronic kidney disease and osteoarthritis: a new comorbid mouse model
RMD Open 2023cited by 19position: middledoi
Rescue of High Glucose Impairment of Cultured Human Osteoblasts Using Cinacalcet and Parathyroid Hormone
Calcified Tissue International 2023cited by 5position: middledoi
Biopolymer‐Based Multilayer Microparticles for Probiotic Delivery to Colon
Advanced Healthcare Materials 2022cited by 42position: middledoi
Preventing osteolytic lesions and osteomyelitis in multiple myeloma
Journal of bone oncology 2022cited by 11position: lastdoi
Dynamic flow and shear stress as key parameters for intestinal cells morphology and polarization in an organ-on-a-chip model
Biomedical Microdevices 2021cited by 76position: middledoi
Highly substituted calcium silicates 3D printed with complex architectures to produce stiff, strong and bioactive scaffolds for bone regeneration
Applied Materials Today 2021cited by 28position: middledoi
Citrus Peel Flavonoids as Potential Cancer Prevention Agents
Current Developments in Nutrition 2020cited by 134position: middledoi
Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children
Frontiers in Endocrinology 2020cited by 53position: firstdoi
Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function
Journal of Cachexia Sarcopenia and Muscle 2019cited by 129position: middledoi
FGF23, Hypophosphatemia, and Emerging Treatments
JBMR Plus 2019cited by 62position: middledoi
From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis
American Journal of Medical Genetics Part A 2019cited by 14position: middledoi
Microalgae as a source of vitamin K1
Algal Research 2018cited by 101position: middledoi
Formation of porous biodegradable scaffolds based on poly(propylene carbonate) using gas foaming technology
Materials Science and Engineering C 2018cited by 94position: middledoi
Simulating Inflammation in a Wound Microenvironment Using a Dermal Wound‐on‐a‐Chip Model
Advanced Healthcare Materials 2018cited by 81position: middledoi
Printed, Flexible pH Sensor Hydrogels for Wet Environments
Advanced Materials Technologies 2018cited by 55position: middledoi
Preclinical models for orthopedic research and bone tissue engineering
Journal of Orthopaedic Research® 2017cited by 52position: firstdoi
Fabrication of a Biodegradable Implant with Tunable Characteristics for Bone Implant Applications
Biomacromolecules 2017cited by 52position: middledoi
Sclerostin Antibody Augments the Anabolic Bone Formation Response in a Mouse Model of Mechanical Tibial Loading
Journal of Bone and Mineral Research 2017cited by 34position: middledoi
Effect of collagen‐glycosaminoglycan scaffold pore size on matrix mineralization and cellular behavior in different cell types
Journal of Biomedical Materials Research Part A 2015cited by 96position: middledoi
A collagen–hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates
Acta Biomaterialia 2014cited by 119position: middledoi
Mechanical Load Increases in Bone Formation via a Sclerostin-Independent Pathway
Journal of Bone and Mineral Research 2014cited by 110position: middledoi
Update from the 2013 international neurofibromatosis conference
American Journal of Medical Genetics Part A 2014cited by 19position: middledoi
NF1 is a critical regulator of muscle development and metabolism
Human Molecular Genetics 2013cited by 82position: lastdoi
Approaches to Treating NF1 Tibial Pseudarthrosis
Journal of Pediatric Orthopaedics 2013cited by 65position: middledoi
Nanoscale Chemical Interaction Enhances the Physical Properties of Bioglass Composites
ACS Nano 2013cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fariba Dehghani · The University of Sydney11 papers (2013–2024)David G. Little · Royal United Hospital Bath NHS Trust8 papers (2013–2022)Peter Valtchev · The University of Sydney6 papers (2018–2024)John M. Kavanagh · The University of Sydney3 papers (2018–2024)Aiken Dao · Westmead Institute for Medical Research3 papers (2021–2023)Alexandra K O’Donohue · The University of Sydney3 papers (2023–2025)Ciara M. Murphy · Trinity College3 papers (2013–2015)Michelle M. McDonald · The University of Sydney3 papers (2014–2022)Timothy Schofield · Senseonics (United States)2 papers (2022–2024)Yiwei Wang · Shenyang Medical College2 papers (2017–2018)Ina Krämer · Novartis (Switzerland)2 papers (2014–2017)Peter Maitz · Concord Repatriation General Hospital2 papers (2017–2018)Lauren Peacock · Amgen (United States)2 papers (2014–2017)Thi Yen Loan Le · Westmead Institute for Medical Research2 papers (2018–2018)Andrew Biggin · University of Liverpool2 papers (2019–2020)Iman Manavitehrani · University of Sydney2 papers (2017–2018)Mateusz Kolanczyk · Charité - Universitätsmedizin Berlin2 papers (2013–2013)Sina Naficy · The University of Sydney2 papers (2018–2018)Michaela Kneissel · Novartis (Switzerland)2 papers (2014–2017)Alyson Morse · The University of Sydney2 papers (2014–2017)